Deutsche Bank’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.2M Sell
369,502
-25,020
-6% -$692K ﹤0.01% 986
2025
Q1
$8.76M Buy
394,522
+252,125
+177% +$5.6M ﹤0.01% 1037
2024
Q4
$2.82M Buy
142,397
+62,083
+77% +$1.23M ﹤0.01% 1628
2024
Q3
$2.01M Buy
+80,314
New +$2.01M ﹤0.01% 1712
2024
Q2
Sell
-91,744
Closed -$1.81M 3558
2024
Q1
$1.81M Buy
91,744
+385
+0.4% +$7.6K ﹤0.01% 1694
2023
Q4
$1.6M Sell
91,359
-367
-0.4% -$6.44K ﹤0.01% 1766
2023
Q3
$1.59M Buy
91,726
+2,220
+2% +$38.6K ﹤0.01% 1450
2023
Q2
$1.26M Sell
89,506
-9,069
-9% -$128K ﹤0.01% 1855
2023
Q1
$1.06M Buy
98,575
+23,316
+31% +$251K ﹤0.01% 2061
2022
Q4
$1.13M Sell
75,259
-1,053
-1% -$15.8K ﹤0.01% 1975
2022
Q3
$980K Buy
76,312
+84
+0.1% +$1.08K ﹤0.01% 1978
2022
Q2
$739K Sell
76,228
-1,430
-2% -$13.9K ﹤0.01% 2357
2022
Q1
$772K Sell
77,658
-2,709
-3% -$26.9K ﹤0.01% 2488
2021
Q4
$946K Buy
80,367
+1,255
+2% +$14.8K ﹤0.01% 2455
2021
Q3
$901K Sell
79,112
-543
-0.7% -$6.18K ﹤0.01% 2676
2021
Q2
$1.11M Sell
79,655
-35,980
-31% -$501K ﹤0.01% 2694
2021
Q1
$2.14M Buy
115,635
+90,931
+368% +$1.68M ﹤0.01% 2115
2020
Q4
$436K Buy
24,704
+9,452
+62% +$167K ﹤0.01% 2974
2020
Q3
$233K Buy
15,252
+5,136
+51% +$78.5K ﹤0.01% 3104
2020
Q2
$257K Buy
10,116
+5,425
+116% +$138K ﹤0.01% 2978
2020
Q1
$72K Sell
4,691
-282
-6% -$4.33K ﹤0.01% 3326
2019
Q4
$54K Buy
4,973
+1,121
+29% +$12.2K ﹤0.01% 3828
2019
Q3
$31K Sell
3,852
-5,707
-60% -$45.9K ﹤0.01% 4002
2019
Q2
$127K Sell
9,559
-4,205
-31% -$55.9K ﹤0.01% 3965
2019
Q1
$246K Buy
13,764
+6,783
+97% +$121K ﹤0.01% 3807
2018
Q4
$195K Sell
6,981
-7,716
-53% -$216K ﹤0.01% 3786
2018
Q3
$374K Buy
+14,697
New +$374K ﹤0.01% 3872